, Tracking Stock Market Picks
Enter Symbol:
Intermune, Inc. (ITMN) [hlAlert]

up 417.50 %

Intermune, Inc. (ITMN) rated Buy by Merriman

Posted on: Wednesday,  Aug 12, 2009  8:25 AM ET by Merriman

Merriman rated Buy Intermune, Inc. (NASDAQ: ITMN) on 08/12/2009, when the stock price was $14.28. Since
then, Intermune, Inc. has gained 417.51% as of 09/26/2014's recent price of $73.90.
If you would have followed this Merriman's recommendation on ITMN, you would have gained 417.5% of your investment in 1871 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

Merriman provides advanced tools for acquiring such information. These tools integrate a combination of cycles, geocosmic signatures and trend analysis patterns in assisting the serious investor in their interpretation of the various financial markets and the general economy. In today's fast paced and seemingly chaotic marketplace, you need the edge that only a broader analysis of human activity can provide.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/12/2009 8:25 AM Buy
as of 12/31/2009
1 Week up  165.43 %
1 Month up  226.72 %
3 Months up  120.27 %
1 YTD up  145.72 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy